Latest Blogs

Jan 16, 2019
Dr. Jean Rene V. Clemenceau Valdivia describes the shared history of the Sociedad Mexicana de Oncologia and ASCO, and the new formal partnership that will guide future collaboration between the two societies.
Jan 14, 2019
Social injustice is perpetuated when patients can't afford to participate in essential clinical research.
Jan 08, 2019
Although there’s never a bad time to make a positive commitment in your life, something about opening the calendar to January 1 feels like the right moment to set an intention.
Jan 03, 2019
Dr. Pesona Grace Lucksom's career journey has been shaped by a series of battles with hormones and their impact on women's health, and this is a fight she intends to win.
Subscribe to this column

Julie Vose, MD, MBA, FASCO

Julie M. Vose, MD, MBA, FASCO, is the 2015-2016 President of ASCO. She is the Neumann M. and Mildred E. Harris Professorial Chair and Chief of the Oncology/Hematology Division in the Department of Internal Medicine at the University of Nebraska Medical Center. She is also the Associate Director of Clinical Research at the Fred and Pamela Buffett Cancer Center.

In addition to being ASCO President, Dr. Vose also serves on the Special Awards Selection and Health Disparities Committees. An ASCO member since 1991, Dr. Vose has served on the Board of Directors, Nominating Committee, Scientific Program Committee, Hematology-Oncology Task Force, Cancer.Net Advisory Panel and Editorial Board, and Journal of Clinical Oncology Editorial Board. She served as Chair of the Cancer Education Committee and Publications Committee. Follow Dr. Vose on Twitter at @DrJulieVose.

Oct 21, 2015
Dear ASCO Member: Over the past year the American Board of Internal Medicine (ABIM) has engaged with ASCO and other stakeholders to listen to the concerns of physicians and redesign their Maintenance of Certification (MOC) program. We have advocated for reform and the ABIM is responding.  The...
Sep 22, 2015
In the latest workforce study for oncology conducted by ASCO, approximately 30% of practicing oncologists were women. However, this number is expected to grow.
Aug 04, 2015
Clinical investigation forms the backbone and the history of medical oncology. Cancer clinical trials provide the evidence we need to demonstrate safety and efficacy before Food and Drug Administration (FDA) approval and evidence for our clinical treatment guidelines. However, it seems to be more...
Jul 10, 2015
As physicians who take care of patients with cancer, all of us worldwide have the same goals of cancer prevention, early detection and screening, improvement in the quality of cancer care, and accelerating research and new therapies. The question is, how can we accomplish these goals in a world...
Jun 01, 2015
In 1964, when the first seven physicians who founded ASCO met, I doubt they imagined what a successful Society they were forming. At that time, cancer treatments were just beginning to have some early successes with a few cytotoxic therapies, new radiation modalities, and improved surgical...

Pages